Generic drugmaker Viatris (NASDAQ:VTRS) has been £1.5M by the U.K.'s Competition and Markets Authority (CMA) for failing to comply with compulsory restrictions imposed during the regulator’s review of ...

Viatris did not immediately respond to a Reuters request for comment. Theramex, one of the largest suppliers of hormone ...

Duphaston and Femoston, which comprise progesterone and estrogen receptor agonists, are prescribed as hormone replacement therapy (HRT) to help relieve menopause symptoms. Following a Phase 1 ...

The U.K. Competition Appeal Tribunal (CAT) has imposed its own fines on Pfizer and Flynn Pharma for abusing their dominant positions by ...